Riva Alessandro Insider Trades

Insider Trading History

Track insider trading activity for Riva Alessandro. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Bicycle Therapeutics Plc
Bicycle Therapeutics Plc BCYC
Director
Holding Value $84.9k 19,880 shares
Last Trade
Jan 02, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$148k 22,141 shares
$6.68
$4.27
Century Therapeutics
Century Therapeutics IPSC
Director
Holding Value $96.8k 44,000 shares
Last Trade
Jun 12, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$26.4k 44,000 shares
$0.60
$2.20
BeiGene
BeiGene BGNE
Director
Holding Value $10.5M 56,940 shares
Last Trade
May 21, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.2M 22,750 shares
$184.71
$184.71
Bicycle Therapeutics Plc
Bicycle Therapeutics Plc BCYC
Director
Holding Value $107k 25,000 shares
Last Trade
Mar 25, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$230k 25,000 shares
$9.20
$4.27
Century Therapeutics
Century Therapeutics IPSC
Director
Holding Value $96.8k 44,000 shares
Last Trade
Jun 20, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$118k 44,000 shares
$2.69
$2.20
BeiGene
BeiGene BGNE
Director
Holding Value $8.49M 45,955 shares
Last Trade
Jun 05, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$5.43M 34,151 shares
$159.03
$184.71
Century Therapeutics
Century Therapeutics IPSC
Director
Holding Value $96.8k 44,000 shares
Last Trade
Jun 27, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$140k 44,000 shares
$3.19
$2.20
BeiGene
BeiGene BGNE
Director
Holding Value $5.47M 29,614 shares
Last Trade
Jun 15, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$5.42M 26,975 shares
$201.04
$184.71
BeiGene
BeiGene BGNE
Director
Holding Value $6.4M 34,645 shares
Last Trade
Jun 22, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$5.39M 34,645 shares
$155.68
$184.71
Century Therapeutics
Century Therapeutics IPSC
Director
Holding Value $43.7k 19,872 shares
Last Trade
Jun 09, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$170k 19,872 shares
$8.56
$2.20
BeiGene
BeiGene BGNE
Director
Holding Value $4.17M 22,581 shares
Last Trade
Feb 28, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.75M 22,581 shares
$210.52
$184.71
Century Therapeutics
Century Therapeutics IPSC
Director
Holding Value $43.7k 19,872 shares
Last Trade
Jun 17, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$2.20
Century Therapeutics
Century Therapeutics IPSC
Director
Holding Value $0 0 shares
Last Trade
Jun 17, 2021 Sale
No data
No data
$2.20

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up